S.No.

NAME OF PROJECT

PUBLICATION DETAIL

01.

A multicentric Clinical Verification of  pathogenesis of 08 drugs prove by council with prognostic factor research-An open clinical trial(2018-2023)

With enrolled cases under the drugs

1. Acorus calamus(47)

2. Apium graveolens (41)

3. Brassica oleracia(40)

 4. Cochlearea armoracia (37)

5. Datura arborea (40)

6. Datura metel (43)

7. Leucas aspera (46)

8. Withania somnifer(35)

Exploring the Homeopathic Therapeutic Potential of Acorus calamus: A Multi-center Open-Label Clinical Verification Studys:Homoeopathy;  DOI https://doi.org/ 10.1055/a-2625-0202: ISSN 1475-4916; September 8, 2025,pg.78-88

02.

Homoeopathy for Menstrual Health in Adolescent School – Going Girls : A Public Health Research (Phase I)

Number of total screen girls - 400

03.

Clinical Verification of 23 drugs: (with no. of enrolled cases)

1. Agave Americana (10)
2. Andographispaniculata (43)
3. ArgemoneMexicana (44)
4. Bacopamoniere (6)
5. Cheloneglabra (14)
6. Clerodendron (12)
7. Coleus aromaticus (10)
8. Cornuscircinata (11)
9. Cuprum oxydatumnigrum (6)
10. Ficusreligiosa (16)
11. Formic acid (6)
12. Hydrocotyleasciatica (13)
13. Juglansregia (3)
14. Liatrisspicata (16)
15. Mimosa humalis (73)
16. Ocimim sanctum (25)
17. Paraffin (39)
18. Pothosfoetidus (7)
19. Senega (55)
20. Skookum chuck (23)
21. Thymol (8)
22. Thyroidinum (4)
23. Tinosporacordifolia (56)

Related publication of 23 drugs in between year of 2017 to 2022

1. Formic acid: A Multicentric observational homoeopathic Clinical verification trial, IJRH, October – December 2016,Volume10,Issue 4, Page Nos, 249-257, by CCRH.
2. Prevalence and prognostic factor in patients with good therapeutic response in a cohort of 172 patients with the homoeopathic medicine

  Araneadiadema: A Multicentric open – label observational study.

IJRH, vol. 12, Issue1, Jan-Mar2018, p20-25

3. Study of homoeopathic medicines through clinical verification. A new perspective, Vol. IV, 2018
4. Monograph on Homoeopathic drug Bellisperennis, 2018
5. Exploring the predictive value of specific symptoms as prognostic factor, Assesment of group confined likelihood ratio for symptom ‘headache’ in 20 lesser known drugs; IJRH Vol. 13, Issue1, p 4-8, Jan-Mar 2019
6.  Retrospective estimation of prevalence and likelihood ratio of general symptoms of 29 less frequently prescribed homoeopathic Medicines by clinical verification. IJRH- Apr-Jun 2019,Vol-13, Issue-2, P 72-80..

04.

Clinical Verificatin of 16 drugs: (With no. of enrolled cases)April 2014 october 2018

1. Allium Sativam (11)
2. Amoorarohituka(36)
3. Asclepiascurrassavica(30)
4. Avenasativa(9)
5. Azathioprine(26)
6. Buxusserpervirens(38)
7. Caeslpiniabonducella(6)
8. Cardiospermumhalicabum(2)
9. Cyclosporin(11)
10. Cynarasoclymus(37)
11. Foeniculumvulgare(43)
12. Gymnemasylvestre(13)
13. Hygrophiliaspinosa(53)
14. Magnolia grandiflora(45)
15. Parseaamericna(10)
16. Psoraliacorylifolia(12)

1. Study of homoeopathic medicines through clinical verification. A new perspective, Vol. V, 2021.

05.

Evaluation of Homoeopathic treatment in the Out-Patient Department- A Patient reported Outcome Study

The Study has been started since December 2017 and concluded on October 2019. The concluding report with excel sheet has been submitted to Hqrs for analysis.

No. Of cases Screen – 173

No. Of cases Enroll – 173

06.

Schedule Caste Sub Plan Programme

The Study has been started since February 209 and concluded on March 2021. The concluding report with excel sheet has been submitted to Hqrs for analysis.

Total no. of camps conducted – 337

Total .o. of patients treated – 13944

(Beneficiary – 13944)

07.

Assessment of most frequently used subric and medicine in homoeopathic treatment of acute condition by Indian homoeopathic practitioner/ researcher (CCRH) with the aid of Vithoulkas compass (VC)

The Study has been started since 19/05/2018 and concluded on 31 December 2020. The concluded report has been submitted to Hqrs. The VC manuscript is under review in a Journal.

Total No. of cases enter VC – 615

No. Of cases with minimum 4follow ups treated successfully – 83

08.

Distributions of Homeo prophylaxis ‘Arsalb’ 30 during COVID – 19’ under Schedule Caste Sub Plan (SCSP)

The programme has been conducted during the year 2020 from June to September 2020 underSchedule Caste Sub Plan (SCSP) programme Under this programme Ars. Alb 30 were distributed among 4420 beneficiaries of two nearby villages
Jagmal Bigha&RohanTola as Homeo prophylaxis for COVID -19’ The details data already have been sent to Hqrs for analysis.

09.

Management of Adjustment Disorders with homoeopathic intervention- A prospective, aingle arm, open label, exploratory, interventional study

The study has been started in January 2019 the enrolment has started in August 2019 after some modification in protocol.

The case enrolments have been concluded on 31-03-2022.

Total Screen cases 90 out of which 38 cases enrolled.

Male – 15

Female – 22

Droupout – 01

10.

Documentation of efficacy of select Ayush interventions, Ayush – 64 & KabasuraKudineerin asymptomatic and mild to modeate COVID-19 patients in home isolation.

Date of initiation: June 2021

Target : 150, Enrolled: 166

Baseline Data:- 1^st Day :166, 7^th Day : 166, 14^th Day: 165, 21^st Day: 156

11.

Homoeopathic Prophylactic Medicine Arsenic album 30 among the population for COVID-19 during celebration of “AzadikaAmritMahotsav” to commemorate 75^th year of Independence.

Total no. of beneficiary [30/08/2021-02/09/2021]-10,068

Male-4043 Female-6025

Total no. of beneficiary[01/09/21-15/08/22]-78,058

12.

Concurrent Drug utilization evalution including medication adherence of
Arsenicum Album 30 as prophylactic medicine and immunity booster against COVID-19: as descriptive, cross sectional research study

Study perid:-29^th September 2022 to 17^th Novemeber 2022

Target:-606

Enrolled:-606